JP MORGAN/CALL/ELI LILLY & CO/810/0.01/20.09.24 | Market Closed - Bid/Ask 06:12:09 2024-06-27 EDT | After market 15:19:08 | |||
| 1.13 EUR | +8.65% |
|
1.125 | -0.44% |
| Current month | +65.08% | ||
| 1 month | +76.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 1.13 | +8.65% |
| 24-06-25 | 1.04 | +4.00% |
| 24-06-24 | 1 | 0.00% |
| 24-06-21 | 1 | -2.91% |
| 24-06-20 | 1.03 | -2.83% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 06:12 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JK2EY5 |
| ISIN | DE000JK2EY58 |
| Date issued | 2024-02-08 |
| Strike | 810 $ |
| Maturity | 2024-09-20 (85 Days) |
| Parity | 100 : 1 |
| Emission price | 0.33 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.13 € |
|---|---|
| Lowest since issue | 0.29 € |
| Delta | 0.8x |
| Omega | 5.983 |
| Premium | 2.91x |
| Gearing | 7.51x |
| Moneyness | 1.116 |
| Difference Strike | -94.4 $ |
| Difference Strike % | -11.65% |
| Spread | 0.01 € |
| Spread % | 0.88% |
| Theoretical value | 1.125 |
| Implied Volatility | 33.16 % |
| Total Loss Probability | 24.97 % |
| Intrinsic value | 0.8793 |
| Present value | 0.2457 |
| Break even | 930.43 € |
| Theta | -0.02x |
| Vega | 0.01x |
| Rho | 0.01x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Warrants
- Warrant
